All lobbying filings

ARTEMIS POLICY GROUP LLC

Lobbying for NATIONAL BLEEDING DISORDER FOUNDATION (FKA NATIONAL HEMOPHILIA FOUNDATION) · Nonprofit supporting patients with inheritable bleeding disorders.

Filing 1st Quarter - Report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 21, 2025

Income

$50,000.00

What the client paid this registrant for the period.

Client based in

New York

Official filing document

Lobbyists on this filing 2

JOHANNA GRAY

Previously held: Intern, Senator Barack Obama
LESLIE BRADY

Previously held: Health Policy Advisor/Legislative Assistant, Rep. Brian Higgins

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 6

Centers For Medicare and Medicaid Services (CMS)
Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
Internal Revenue Service (IRS)
SENATE
Treasury, Dept of

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 5

HR 864
Freedom to Cooperate Act
HR 9774
Health Care Affordability Act of 2024
S 5194
Health Care Affordability Act of 2024
HR 1796
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
S 735
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025

Lobbying activity 6

Medicare/Medicaid

Reimbursement for hemophilia services and treatments in Medicare Reimbursement for hemophilia services and treatments in Medicaid Issues related to 1115 Waivers in Medicaid Preserving and expanding access to Medicaid

Health Issues

Blood and plasma safety and awareness Bleeding disorders awareness

Insurance

Implementation of the Affordable Care Act The HELP Copays Act (HR 864) Coverage of hemophilia treatments and services in private insurance plans, including the alternative funding model Policies related to copay accumulator adjustor and maximizer programs Policies related to PBM regulation Healthcare Affordability Act of 2024 (H.R. 9774 / S. 5194) Policies related to the extension of enhanced advanced premium tax credits Protect patients from substandard and junk insurance products House Ways and Means Committee Request for Information - Tax Priorities Patient Protection and Affordable Care Act; HHS Proposed Marketplace Integrity and Affordability Rule (CMS-9884-P)

Budget/Appropriations

Funding for federal hemophilia programs in FY25 House and Senate Labor-HHS Appropriations bills NIH FY25 appropriations

Pharmacy

Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program

Medical/Disease Research/Clinical Labs

Hemophilia research, prevention, surveillance and service programs and issues Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act (H.R. 1796/S. 735)

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.